deoxypyridinoline has been researched along with Cancer of the Uterus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caird, LE; Gow, SM; Hannan, WJ; Lumsden, MA; West, CP | 1 |
| Minaguchi, H; Taga, M | 1 |
1 trial(s) available for deoxypyridinoline and Cancer of the Uterus
| Article | Year |
|---|---|
Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability.
Topics: Adult; Amino Acids; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Density; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms; Uterus | 1997 |
1 other study(ies) available for deoxypyridinoline and Cancer of the Uterus
| Article | Year |
|---|---|
Change in C-terminal cross-linking domain of type I collagen in urine, a new marker of bone resorption, during and after gonadotropin-releasing hormone agonist administration.
Topics: Adult; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Resorption; Buserelin; Collagen; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Leiomyoma; Middle Aged; Nafarelin; Uterine Neoplasms | 1997 |